These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21605820)

  • 41. [Acute linear IgA bullous dermatosis with circulating IgA monoclonal antibody associated with Hodgkin's disease].
    Gantzer A; Bouaziz JD; Valeyrie-Allanore L; Ingen-Housz-Oro S; Ortonne N; Bagot M
    Ann Dermatol Venereol; 2010 Dec; 137(12):819-20. PubMed ID: 21134587
    [No Abstract]   [Full Text] [Related]  

  • 42. Oral health related qualıty of lıfe and dısease severıty ın autoımmune bullous dıseases.
    Bilgic A; Aydin F; Sumer P; Keskiner I; Koc S; Bozkurt S; Mumcu G; Alpsoy E; Uzun S; Akman-Karakas A
    Niger J Clin Pract; 2020 Feb; 23(2):159-164. PubMed ID: 32031089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Role of Mast Cells in Autoimmune Bullous Dermatoses.
    Yu X; Kasprick A; Hartmann K; Petersen F
    Front Immunol; 2018; 9():386. PubMed ID: 29541076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A case of bullous disease limited to the skin illustrates the spectrum of neoplasia-induced autoimmunity.
    Grover RK; Stites PC; Helm TN; Hashimoto T; Beutner EH
    Dermatol Online J; 2009 Jul; 15(7):5. PubMed ID: 19903433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Achieving Diagnosis: Importance of Proper Biopsy in Autoimmune Bullous Disorders.
    Patel VM; Sylvester M; Baldev K; John AM; Lambert WC
    Skinmed; 2017; 15(2):129-131. PubMed ID: 28528608
    [No Abstract]   [Full Text] [Related]  

  • 46. [Impairment of cell adhesion in autoimmune bullous skin diseases].
    Müller E; Caldelari R; de Bruin A; Suter MM
    Schweiz Arch Tierheilkd; 2000 May; 142(5):241-6. PubMed ID: 10850158
    [No Abstract]   [Full Text] [Related]  

  • 47. Quality of life index in autoimmune bullous dermatosis patients.
    Penha MÁ; Farat JG; Miot HA; Barraviera SR
    An Bras Dermatol; 2015; 90(2):190-4. PubMed ID: 25830988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Practical management of the most common autoimmune bullous diseases].
    Suárez-Fernández R; España-Alonso A; Herrero-González JE; Mascaró-Galy JM
    Actas Dermosifiliogr; 2008; 99(6):441-55. PubMed ID: 18558052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Case of linear immunoglobulin A bullous dermatosis associated with acquired hemophilia.
    Arakaki O; Yamamoto Y; Awazawa R; Nonaka K; Taira K; Asato Y; Hagiwara K; Oyama B; Ishii N; Hashimoto T; Uezato H
    J Dermatol; 2008 Jul; 35(7):437-46. PubMed ID: 18705832
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of autoimmune blistering diseases on work productivity.
    Wang EQ; Radjenovic M; Castrillón MA; Feng GHY; Murrell DF
    J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):1959-1966. PubMed ID: 29730897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases.
    Hertl M; Zillikens D; Borradori L; Bruckner-Tuderman L; Burckhard H; Eming R; Engert A; Goebeler M; Hofmann S; Hunzelmann N; Karlhofer F; Kautz O; Lippert U; Niedermeier A; Nitschke M; Pfütze M; Reiser M; Rose C; Schmidt E; Shimanovich I; Sticherling M; Wolff-Franke S
    J Dtsch Dermatol Ges; 2008 May; 6(5):366-73. PubMed ID: 18201220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Animal models for autoimmune bullous dermatoses.
    Bieber K; Sun S; Ishii N; Kasperkiewicz M; Schmidt E; Hirose M; Westermann J; Yu X; Zillikens D; Ludwig RJ
    Exp Dermatol; 2010 Jan; 19(1):2-11. PubMed ID: 19702839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases' patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires.
    Saleh MA; Zaraa I; Doss N; Saleh NA; Murrell DF
    An Bras Dermatol; 2019; 94(4):399-404. PubMed ID: 31644610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of recombinant antigen-based assays for diagnosis of bullous autoimmune diseases.
    D'Agosto G; Latini A; Carducci M; Mastroianni A; Vento A; Fei PC
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):762-5. PubMed ID: 15242953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vitamin D status in patients with autoimmune bullous dermatoses: a meta-analysis.
    Yang M; Wu H; Zhao M; Long H; Lu Q
    J Dermatolog Treat; 2022 May; 33(3):1356-1367. PubMed ID: 32799714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bullous dermatoses of pregnancy.
    Honeyman JF; Eguiguren G; Pinto A; Honeyman AR; de la Parra MA; Navarrete W
    Arch Dermatol; 1981 May; 117(5):264-7. PubMed ID: 7013716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Bullous dermatoses. Introduction].
    Ortonne N
    Ann Pathol; 2013 Jun; 33(3):171-7. PubMed ID: 23790656
    [No Abstract]   [Full Text] [Related]  

  • 58. From bedside to bench and back. The diagnosis and biology of bullous diseases.
    Yancey KB
    Arch Dermatol; 1994 Aug; 130(8):983-7. PubMed ID: 8053715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of Regulatory Immune Cells and Molecules in Autoimmune Bullous Dermatoses.
    Cao T; Shao S; Fang H; Li B; Wang G
    Front Immunol; 2019; 10():1746. PubMed ID: 31428090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reliability of the autoimmune bullous disease quality of life (ABQOL) questionnaire in the USA.
    Sebaratnam DF; Okawa J; Payne A; Murrell DF; Werth VP
    Qual Life Res; 2015 Sep; 24(9):2257-60. PubMed ID: 25795375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.